Viveve Medical
VIVE
#10148
Rank
NZ$0 M
Marketcap
$0.0001713
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

P/E ratio for Viveve Medical (VIVE)

P/E ratio as of November 2024 (TTM): 0.0000

According to Viveve Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.77358E-5. At the end of 2021 the company had a P/E ratio of -0.4254.

P/E ratio history for Viveve Medical from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-0.425466.62%
2020-0.25531079.58%
2019-0.0216-96.64%
2018-0.6439-72.27%
2017-2.320.11%
2016-2.32-2.88%
2015-2.39348.58%
2014-0.5325-107.62%
20136.99-1595.04%
2012-0.4674-13.41%
2011-0.5398-86.02%
2010-3.8641.39%
2009-2.73198.28%
2008-0.9155-82.98%
2007-5.38-139.28%
200613.7-217.28%
2005-11.7-58.42%
2004-28.1-142.27%
200366.417.99%
200256.3-1371.05%
2001-4.43

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-37.0 98,133,767.57%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-1.18 3,123,114.56%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.